WWOX Phosphorylation, Signaling, and Role in Neurodegeneration

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The tumor suppressor WWOX (Walker-Warburg syndrome) is crucial for preventing neural and metabolic disorders.
• WWOX downregulation in Alzheimer's disease (AD) hippocampi suggests a role in neurodegeneration.
• Protein aggregation, including TRAPPC6AΔ and TIAF1, occurs sequentially and is linked to aging and neurodegenerative diseases.

Purpose of the Study:

• To investigate the role of WWOX in preventing protein aggregation.
• To explore the neuroprotective mechanisms of WWOX, including its interaction with 17β-estradiol (E2).
• To evaluate the potential of the Zfra peptide in restoring memory loss.

Main Methods:

• In vitro knockdown of WWOX in neuroblastoma cells to observe protein aggregation.
• Analysis of protein aggregates in human brain samples across different age groups.
• Biochemical assays to study the interaction between WWOX, E2, and Tau-hyperphosphorylating enzymes (e.g., GSK-3β).
• Assessment of memory restoration in mice using the Zfra peptide.

Main Results:

• WWOX knockdown induces sequential aggregation of TRAPPC6AΔ, TIAF1, amyloid β, and Tau.
• TRAPPC6AΔ and TIAF1 aggregates are found in healthy mid-aged individuals, indicating early-stage aggregation.
• WWOX binds and inhibits Tau-hyperphosphorylating enzymes, promoting neuronal survival.
• 17β-estradiol binds WWOX, enhancing its neuroprotective function.
• The Zfra peptide demonstrated memory restoration in mice.

Conclusions:

• WWOX plays a critical role in preventing the cascade of protein aggregation associated with neurodegeneration.
• The WWOX-E2 interaction offers a potential therapeutic strategy for neuroprotection.
• The Zfra peptide shows promise for treating memory deficits in neurodegenerative conditions.